A case of very late stent thrombosis after bare metal coronary stent implantation: A neglected complication

Çelik, Turgay; İyisoy, Atila; Çelik, Murat; Işık, Ersoy

doi:10.1016/j.ijcard.2007.08.073

Cited by 4 publications

(5 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…And we deeply welcome the interesting case description, reported by the same authors [2]. We completely agree with the overall conclusions of Celik et al when they state that very late stent thrombosis (VLST) can occur also after implantation of bare metal stents (BMS).…”

supporting

confidence: 87%

Reply to “A case of very late stent thrombosis after bare metal coronary stent implantation: A neglected complication”

Agostoni¹

2009

International Journal of Cardiology

View full text Add to dashboard Cite

supporting

confidence: 87%

Reply to “A case of very late stent thrombosis after bare metal coronary stent implantation: A neglected complication”

Agostoni¹

2009

International Journal of Cardiology

View full text Add to dashboard Cite

“…Four categories of ST after stent implantation. 14,15 [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.] endothelialization, stent design, covered stents, and so on.…”

Section: Metals For Stentsmentioning

confidence: 99%

“…Four categories of ST after stent implantation . [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.…”

Section: Introductionmentioning

confidence: 99%

“…ST is a major complication after PCI, resulting in high rates of death and nonfatal myocardial infarction. In general, ST can be divided into four categories, which are shown in Figure : (i) acute ST, which is defined as thrombosis occurring 0–24 h after stent deployment; (ii) subacute ST, which occurs 1–30 days after stent implantation; (iii) late ST, which occurs after 30 days to 1 year; and (iv) very late stent thrombosis (VLST), which occurs more than 1 year after stent implantation. The pathophysiological mechanisms of acute and subacute ST after BMS and drug‐eluting stent (DES) deployment are similar.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Surface modification of implanted cardiovascular metal stents: From antithrombosis and antirestenosis to endothelialization

Zhang

Liu

et al. 2013

J Biomedical Materials Res

View full text Add to dashboard Cite

Driven by the complications occurring with bare metal stents and drug-eluting stents, concerns have been raised over strategies for long-term safety, with respect to preventing or inhibiting stent thrombosis, restenosis, and in-stent restenosis in particularly. Surface modification is very important in constructing a buffer layer at the interface of the organic and inorganic materials and in ultimately obtaining long-term biocompatibility. In this review, we summarize the developments in surface modification of implanted cardiovascular metal stents. This review focuses on the modification of metal stents via coating drugs or biomolecules to enhance antithrombosis, antirestenosis, and/or endothelialization. In addition, we indicate the probable future work involving the modification of the metallic blood-contacting surfaces of stents and other cardiovascular devices that are under development.

show abstract

“…On the contrary, later after BMS placement, the disease progression with formation of vulnerable yellow neointima is a common feature [2] suggesting that a longer time is needed to develop intrastent neoatherosclerosis. Accordingly, disruption of in-stent neoatherosclerotic lesions resulting in stent thrombosis has been reported to occur beyond three years after BMS implantation [3,4]. We present a case of a male patient with very late thrombosis (VLST) occurred 18 years after BMS implantation and 14 days after aspirin discontinuation that underwent primary percutaneous coronary intervention (pPCI) with thrombus aspiration for anterior ST elevation myocardial infarction (STEMI).…”

Section: Introductionmentioning

confidence: 99%

A Case of Very Late Bare-Metal Coronary Stent Thrombosis Two Weeks after Aspirin Discontinuation, Histopathologic Thrombus Findings and Clinical Considerations

Tanzilli¹,

Viceconte²,

Truscelli³

et al. 2017

J Clin Exp Cardiolog

View full text Add to dashboard Cite

There have been consistent evidences that atherosclerotic changes occur inside bare metal stents (BMS) during an extended period after implantation. This report describes the histopathologic features of aspirated material harvested from a patient with definite very late stent thrombosis of a BMS implanted 18 years prior. The patient presented with a recurrent anterior acute myocardial infarction 14 day after aspirin discontinuation. We suggest that vulnerable neointimal tissue inside the stent struts of BMS may be one potential trigger of thrombosis when the protection of aspirin treatment is ceased.

show abstract

A case of very late stent thrombosis after bare metal coronary stent implantation: A neglected complication

Cited by 4 publications

References 11 publications

Reply to “A case of very late stent thrombosis after bare metal coronary stent implantation: A neglected complication”

Reply to “A case of very late stent thrombosis after bare metal coronary stent implantation: A neglected complication”

Surface modification of implanted cardiovascular metal stents: From antithrombosis and antirestenosis to endothelialization

A Case of Very Late Bare-Metal Coronary Stent Thrombosis Two Weeks after Aspirin Discontinuation, Histopathologic Thrombus Findings and Clinical Considerations

Contact Info

Product

Resources

About